Compare Cronos Group Inc (CRON) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Veritone Inc — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while Veritone Inc trades at $1.08 (market cap $98.53M). The key difference: Cronos Group Inc is far larger — about 10.4× Veritone Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| CRON | VERI | |
|---|---|---|
Market Cap | $1.02B | $98.53M |
Sector | Health | Technology |
52-Week High | $3.27 | $8.39 |
52-Week Low | $1.95 | $1.07 |
Enterprise Value | $203.29M | $130.56M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Veritone (VERI) trades at $1.10, down 6.78% in the last 24 hours, with a bearish technical signal despite oversold RSI readings. The company reported revenue of $92.19 million in 2025 but posted a net loss of $111.73 million, with negative profit margins and cash flow challenges. Recent news highlights multiple class action lawsuits alleging securities fraud, creating significant legal overhangs.
Investment outlook remains highly speculative given persistent losses and legal uncertainties. While analyst consensus shows mixed sentiment with 46% buy ratings, fundamental weaknesses and ongoing litigation pose substantial risks. The stock's current valuation at 0.88x sales offers limited protection against operational challenges and potential legal liabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
